- Home
- EAD vs NXPLW Comparison
EAD vs NXPLW Comparison
Compare EAD & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EAD
- NXPLW
- Stock Information
- Founded
- EAD 2003
- NXPLW N/A
- Country
- EAD United States
- NXPLW United States
- Employees
- EAD N/A
- NXPLW 166
- Industry
- EAD Finance/Investors Services
- NXPLW Telecommunications Equipment
- Sector
- EAD Finance
- NXPLW Telecommunications
- Exchange
- EAD Nasdaq
- NXPLW Nasdaq
- Market Cap
- EAD N/A
- NXPLW N/A
- IPO Year
- EAD N/A
- NXPLW N/A
- Fundamental
- Price
- EAD $6.66
- NXPLW $0.16
- Analyst Decision
- EAD
- NXPLW
- Analyst Count
- EAD 0
- NXPLW 0
- Target Price
- EAD N/A
- NXPLW N/A
- AVG Volume (30 Days)
- EAD 178.9K
- NXPLW 6.4K
- Earning Date
- EAD 01-01-0001
- NXPLW 03-31-2025
- Dividend Yield
- EAD 8.91%
- NXPLW N/A
- EPS Growth
- EAD N/A
- NXPLW N/A
- EPS
- EAD N/A
- NXPLW N/A
- Revenue
- EAD N/A
- NXPLW $66,482,000.00
- Revenue This Year
- EAD N/A
- NXPLW N/A
- Revenue Next Year
- EAD N/A
- NXPLW N/A
- P/E Ratio
- EAD N/A
- NXPLW N/A
- Revenue Growth
- EAD N/A
- NXPLW 179.89
- 52 Week Low
- EAD $5.69
- NXPLW $0.25
- 52 Week High
- EAD $6.81
- NXPLW $0.26
- Technical
- Relative Strength Index (RSI)
- EAD 53.35
- NXPLW N/A
- Support Level
- EAD $6.38
- NXPLW N/A
- Resistance Level
- EAD $6.67
- NXPLW N/A
- Average True Range (ATR)
- EAD 0.15
- NXPLW 0.00
- MACD
- EAD 0.04
- NXPLW 0.00
- Stochastic Oscillator
- EAD 98.72
- NXPLW 0.00
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.